OpenAI acquired biotech startup Orchestra Bio to expand its life sciences AI tools

OpenAI says it's adding Orchestra's team and technology to work on Rosalind, its AI model for life sciences research, and to its related Rosalind Workbench tool, a harness that aims to help researchers plan experiments and analyze results.

4 sources20 Oct 2026Updated 31h ago

OpenAI acquired biotech startup Orchestra Bio to expand its life sciences AI tools

Coverage across the spectrum

How we rate outlets

Left 0% · 0Center 100% · 4Right 0% · 0

The story so far

Exclusive: OpenAI has acquired Orchestra Bio.
OpenAI acquires startup Orchestra Bio⁠ to beef up its biotech business.
OpenAI acquires Orchestra Bio to streamline drug development with AI.

Summarised from the linked sources. Methodology

Who's reporting it

Timeline

20h ago
Axios: OpenAI has acquired Orchestra Bio, a startup building AI agents to help pharmaceutical companies manage drug development, the ChatGPT maker
17h ago
TechCrunch (US): OpenAI says it's adding Orchestra's team and technology to work on Rosalind, its AI model for life sciences research, and to its related Ros
8h ago
Business Line - Home (IN): OpenAI has acquired Orchestra Bio, a platform that helps biopharmaceutical companies coordinate drug development, as it looks to combine its
55m ago
qz.com: OpenAI acquired biotech startup Orchestra Bio to expand its life sciences AI tools